The Latest on the Johnson & Johnson and AstraZeneca Vaccines

Dr. Andrea Klemes, Chief Medical Officer MDVIP
By Dr. Andrea Klemes , MDVIP
May 10, 2021
The Latest on the Johnson & Johnson and AstraZeneca Vaccines

Two vaccines used worldwide — only one authorized for emergency use in the U.S.— have come under scrutiny after several cases of rare blood clotting issues. In mid-April, the Centers for Disease Control and Prevention and the Food and Drug Administration paused the administration of the Johnson & Johnson vaccine in the United States. In Europe, where the AstraZeneca vaccine is authorized for use, it has been linked to blood clot issues also. Some European countries are limiting its use to certain age groups and some, like Denmark, have decided to stop use altogether.

These decisions by regulators to suspend or restrict the use of certain vaccines made a lot of headlines and caused concern among patients who have received these vaccines or are still waiting to be vaccinated.

While the suspensions are worrisome — they should not be alarming. First, it shows the system for reporting adverse events is working. Public health regulators are constantly reviewing health data about vaccines (and all drugs for that matter) and acting to keep Americans safe.

Second, these vaccines are already extremely safe by nearly any measure. All vaccines produce adverse effects (see below), but with hundreds of millions of doses delivered, such events have affected very few recipients.

In the case of the J&J and AstraZeneca vaccines, the clots are extremely rare. For example, nearly 7 million doses of the single-shot J&J vaccine have been administered and there are only six reports of people developing blood clots. There have been more clotting incidents with the AstraZeneca vaccine, but tens of millions of doses of that vaccine have been given. In contrast, incidents of blood clots are much higher in people who have contracted COVID-19. 

What’s actually happening?

Patients who received J&J and AstraZeneca’s vaccines have developed a very rare condition called thrombotic thrombocytopenia syndrome (TTS) which may cause cerebral venous sinus thrombosis (CVST). With the J&J vaccine, the six cases reported to date have occurred among women between the ages of 18 and 48 and symptoms have occurred six to 13 days after vaccination with no obvious patterns or common risk factors yet.

While blood clots are commonly treated with drugs like the anticoagulant heparin, this version of CVST was seen in combination with low levels of blood platelets. Platelets are types of blood cells that stop bleeding by clumping and plugging blood vessel injuries. This means doctors will have to turn to alternative treatments.
If you want to dig more deeply into the science, I recommend this article in Nature.

Do vaccines usually have adverse events?

Yes! Vaccines (as well as most medications) almost always have adverse events. Most of these are non-serious and are commonly referred to as side effects. These side effects are well known and generally mild for the three vaccines approved for emergency use in the United States. Much rarer are serious adverse events, which can include life-threatening illnesses like CVST.
But the diseases that vaccines prevent pose a much graver risk. COVID has killed more than 3 million people worldwide and 570,000 in the U.S. It’s infected millions more, resulting in long-term symptoms for some people. The disease is also associated with an increased risk of CVST.

Should you be worried if you got the J&J vaccine?

Probably not. The condition has only occurred in a handful of people who have received the vaccine and then only within two weeks of receiving the vaccine. However, if you’ve experienced any of the following symptoms, you should contact your doctor:

  • Severe headache
  • Blurry vision or shortness of breath
  • Fainting or loss of consciousness
  • Weakness
  • Sensory Changes
  • Confusion or trouble speaking
  • Seizures
  • Abdominal pain
  • Leg pain
  • Difficulty breathing/shortness of breath

Should you avoid the J&J vaccine and get something else?

The administration of the J&J vaccine resumed after a thorough safety review by the FDA and CDC. The agencies also added a new warning to the emergency use authorization for the vaccine. You can read about it here. If you are scheduled to get the vaccine and are worried, you should discuss it with your physician. 

My gut: Get the first vaccine available to you as long as your physician agrees. I had the AstraZeneca vaccine as part of a clinical trial, and I’m not worried. As I told a colleague recently, if your house is about to be washed away in a flood, you take the first transport out of there. You don’t wait for something else to come along.

But if it worries you, there are plenty doses of the Pfizer and Moderna vaccines available, and those have not been linked to CVST. The Pfizer and Moderna are mRNA vaccines, which means they work differently than the J&J vaccine. You can read about how they work here.

The important thing is to get vaccinated. That’s the only way we’re going to end this pandemic.


Similar Posts

About the Author
Dr. Andrea Klemes, Chief Medical Officer MDVIP
Dr. Andrea Klemes
, MDVIP

Dr. Andrea Klemes is the Chief Medical Officer of MDVIP. She also serves as the executive and organizational leader of MDVIP’s Medical Advisory Board that supports quality and innovation in the delivery of the healthcare model drawing expertise from the affiliated physicians. Dr. Klemes oversees MDVIP’s impressive outcomes data and research including hospital utilization and readmission statistics, quality of disease management in the MDVIP network and the ability to identify high-risk patients and intervene early. She is instrumental in the adoption of the Electronic Health Record use in MDVIP-affiliated practices and the creation of the data warehouse. Dr. Klemes is board certified in internal medicine and endocrinology and a fellow of the American College of Endocrinology. Dr. Klemes received her medical degree from the New York College of Osteopathic Medicine. She completed an internal medicine residency at Cabrini Medical Center in Manhattan, New York and an Endocrine and Metabolism Fellowship at the Medical College of Georgia in Augusta. Prior to joining MDVIP, Dr. Klemes worked at Procter & Gamble in the areas of personal healthcare, women’s health and digestive wellness and served as North American Medical Director for bone health. She spent 10 years in private practice specializing in endocrinology and metabolism in Tallahassee, Florida. In addition, Dr. Klemes held leadership roles with the American Medical Association, Florida Medical Association and as Medical Director of the Diabetes Center in Tallahassee and Panama City, Florida, as well as Chief of the Department of Medicine at Tallahassee Community Hospital. She has been a consultant and frequent lecturer and has completed broad clinical research in diabetes and osteoporosis and published extensively.

View All Posts By Dr. Andrea Klemes
FIND A DOCTOR NEAR YOU
Physician Locator
Enter a full address, city, state, or ZIP code. You can also browse our city directory to find physicians in your area.
Enter Doctor's Name
Top